Want to see HK:9939 full AI Analyst Report?
Total Valuation
Kintor Pharmaceutical Ltd has a market cap or net worth of HK$862.49M. The enterprise value is HK$1.06K.
Market CapHK$862.49M
Enterprise ValueHK$1.06K
Share Statistics
Kintor Pharmaceutical Ltd has 498,660,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding498,660,100
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kintor Pharmaceutical Ltd’s return on equity (ROE) is -1.10 and return on invested capital (ROIC) is -66.83%.
Return on Equity (ROE)-1.10
Return on Assets (ROA)-0.59
Return on Invested Capital (ROIC)-66.83%
Return on Capital Employed (ROCE)-0.94
Revenue Per Employee265.71K
Profits Per Employee-1.58M
Employee Count123
Asset Turnover0.10
Inventory Turnover2.04
Valuation Ratios
The current PE Ratio of Kintor Pharmaceutical Ltd is ―. Kintor Pharmaceutical Ltd’s PEG ratio is -0.18.
PE Ratio―
PS Ratio24.23
PB Ratio4.33
Price to Fair Value4.33
Price to FCF-4.77
Price to Operating Cash Flow-4.99
PEG Ratio-0.18
Income Statement
In the last 12 months, Kintor Pharmaceutical Ltd had revenue of 32.68M and earned -200.11M in profits. Earnings per share was -0.44.
Revenue32.68M
Gross Profit8.04M
Operating Income-199.78M
Pretax Income-202.96M
Net Income-200.11M
EBITDA-140.66M
Earnings Per Share (EPS)-0.44
Cash Flow
In the last 12 months, operating cash flow was -149.83M and capital expenditures 50.15M, giving a free cash flow of -99.68M billion.
Operating Cash Flow-149.83M
Free Cash Flow-99.68M
Free Cash Flow per Share-0.20
Dividends & Yields
Kintor Pharmaceutical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.48
52-Week Price Change-23.59%
50-Day Moving Average1.88
200-Day Moving Average2.37
Relative Strength Index (RSI)46.82
Average Volume (3m)4.99M
Important Dates
Kintor Pharmaceutical Ltd upcoming earnings date is Apr 1, 2027, TBA (Confirmed).
Last Earnings DateAug 19, 2026
Next Earnings DateApr 1, 2027
Ex-Dividend Date―
Financial Position
Kintor Pharmaceutical Ltd as a current ratio of 0.43, with Debt / Equity ratio of 122.30%
Current Ratio0.43
Quick Ratio0.34
Debt to Market Cap0.11
Net Debt to EBITDA-0.37
Interest Coverage Ratio-52.00
Taxes
In the past 12 months, Kintor Pharmaceutical Ltd has paid 2.85M in taxes.
Income Tax2.85M
Effective Tax Rate-0.01
Enterprise Valuation
Kintor Pharmaceutical Ltd EV to EBITDA ratio is -6.00, with an EV/FCF ratio of -5.08.
EV to Sales25.81
EV to EBITDA-6.00
EV to Free Cash Flow-5.08
EV to Operating Cash Flow-5.10
Balance Sheet
Kintor Pharmaceutical Ltd has HK$31.79M in cash and marketable securities with HK$133.56M in debt, giving a net cash position of -HK$101.77M billion.
Cash & Marketable SecuritiesHK$31.79M
Total DebtHK$133.56M
Net Cash-HK$101.77M
Net Cash Per Share-HK$0.20
Tangible Book Value Per ShareHK$0.17
Margins
Gross margin is 12.57%, with operating margin of -611.29%, and net profit margin of -612.29%.
Gross Margin12.57%
Operating Margin-611.29%
Pretax Margin-621.01%
Net Profit Margin-612.29%
EBITDA Margin-430.37%
EBIT Margin-527.63%
Analyst Forecast
The average price target for Kintor Pharmaceutical Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast647.17%
EPS Growth Forecast-8.86%